{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03184935",
      "OrgStudyIdInfo": {
        "OrgStudyId": "SCLnow-IMIMH-03"
      },
      "Organization": {
        "OrgFullName": "Sclnow Biotechnology Co., Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Research for Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Myelodysplastic Syndrome (MDS)",
      "OfficialTitle": "Research for Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Myelodysplastic Syndrome (MDS)"
    },
    "StatusModule": {
      "StatusVerifiedDate": "October 2020",
      "OverallStatus": "Suspended",
      "WhyStopped": "Others",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 2021",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "June 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "June 6, 2017",
      "StudyFirstSubmitQCDate": "June 11, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 14, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "September 21, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 23, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Sclnow Biotechnology Co., Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purposes of the study is to determine the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating Myelodysplastic Syndrome patients.",
      "DetailedDescription": "This is a randomized, double-blind, paralleled study. 40 patients will be separated into two groups, and receive basic treatment (Decitabine). Patients in experimental group will receive hUC-MSC, while control group receive placebo (normal saline), four weeks as a course of treatment. All of the patients accept examination before treatment, including\n\ndiagnostic projects: bone marrow test, peripheral blood classification, chromosome, and MDS fusion gene test, etc.;\nroutine examination: blood, urine, and stool routine test, X-ray film in chest, electrocardiogram, etc.;\nstem cell-based medicinal products usage, dosage, time, and course of treatment.\n\nThen, patients will accept routine examination everyday, and after treatment, investigator will follow-up for 6 months, to evaluate the security and efficacy of hUC-MSC."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Myelodysplastic Syndromes"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Myelodysplastic Syndromes",
          "mesenchymal stem cells"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Double",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Investigator"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "40",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Experimental group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Basic medication: Decitabine; Allogeneic umbilical cord mesenchymal stem cells.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Allogeneic umbilical cord mesenchymal stem cells",
                "Drug: Decitabine"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control group",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Basic medication: Decitabine; placebo: saline.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Decitabine"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Allogeneic umbilical cord mesenchymal stem cells",
            "InterventionDescription": "Experimental group receive Allogeneic umbilical cord mesenchymal stem cell，i.v (SCLnow 19#)",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Experimental group"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Decitabine",
            "InterventionDescription": "Decitabine，20mg/m^2/d",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Control group",
                "Experimental group"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Treatment related-adverse events counting",
            "PrimaryOutcomeDescription": "patients will be monitored for any adverse events resulting from the treatment of Human Umbilical Cord Mesenchymal Stem Cells",
            "PrimaryOutcomeTimeFrame": "16 weeks"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Improvement in clinical function",
            "SecondaryOutcomeDescription": "According to 'Diagnostic and Curative Criteria of Hematological Diseases' 3rd edition edited by Zhang Zhinan and Shen Di, evaluate the hUC-MSCs efficacy. The result as follow:\n\ncomplete remission (CR);\npartial remission (PR);\nstable disease (SD);\nprogressive disease (PD)",
            "SecondaryOutcomeTimeFrame": "16 weeks"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMDS patients with international prostate symptom score is moderate or severe symptoms\n\nExclusion Criteria:\n\nwith serious renal function impaired\nwith other organ function abnormal: acute hepatitis B, ejection fraction < 40%, serum bilirubin > 3mg/dl, liver function tests abnormal, central nervous system disease, mental disease\nbad physical condition (Karmofsky < 60%)\nwithout signing informed consent form\nunder other therapy that possibly influence MSC security or efficacy\nHIV or other serious disease infection\nDonor: HIV, active hepatitis B/C infection, Syphilitic antibody positive\nDonor/ participants: alcoholism, drug addicted, mental disease",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "60 Years",
      "MaximumAge": "85 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Shana Chen",
            "OverallOfficialAffiliation": "Inner Mongolia International Mongolian Hospital",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Lei Guo",
            "OverallOfficialAffiliation": "China-Japan Union Hospital, Jilin University",
            "OverallOfficialRole": "Study Chair"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Inner Mongolia International Mongolian Hospital",
            "LocationCity": "Hohhot",
            "LocationState": "Inner Mongolia",
            "LocationZip": "010065",
            "LocationCountry": "China"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000011289",
            "ConditionMeshTerm": "Preleukemia"
          },
          {
            "ConditionMeshId": "D000009190",
            "ConditionMeshTerm": "Myelodysplastic Syndromes"
          },
          {
            "ConditionMeshId": "D000013577",
            "ConditionMeshTerm": "Syndrome"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000004194",
            "ConditionAncestorTerm": "Disease"
          },
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000001855",
            "ConditionAncestorTerm": "Bone Marrow Diseases"
          },
          {
            "ConditionAncestorId": "D000006402",
            "ConditionAncestorTerm": "Hematologic Diseases"
          },
          {
            "ConditionAncestorId": "D000011230",
            "ConditionAncestorTerm": "Precancerous Conditions"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M15507",
            "ConditionBrowseLeafName": "Syndrome",
            "ConditionBrowseLeafAsFound": "Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11297",
            "ConditionBrowseLeafName": "Myelodysplastic Syndromes",
            "ConditionBrowseLeafAsFound": "Myelodysplastic Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M13316",
            "ConditionBrowseLeafName": "Preleukemia",
            "ConditionBrowseLeafAsFound": "Myelodysplastic Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M4286",
            "ConditionBrowseLeafName": "Bone Marrow Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8642",
            "ConditionBrowseLeafName": "Hematologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M13263",
            "ConditionBrowseLeafName": "Precancerous Conditions",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T3993",
            "ConditionBrowseLeafName": "Myelodysplastic Syndromes",
            "ConditionBrowseLeafAsFound": "Myelodysplastic Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC15",
            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000077209",
            "InterventionMeshTerm": "Decitabine"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000000964",
            "InterventionAncestorTerm": "Antimetabolites, Antineoplastic"
          },
          {
            "InterventionAncestorId": "D000000963",
            "InterventionAncestorTerm": "Antimetabolites"
          },
          {
            "InterventionAncestorId": "D000045504",
            "InterventionAncestorTerm": "Molecular Mechanisms of Pharmacological Action"
          },
          {
            "InterventionAncestorId": "D000000970",
            "InterventionAncestorTerm": "Antineoplastic Agents"
          },
          {
            "InterventionAncestorId": "D000004791",
            "InterventionAncestorTerm": "Enzyme Inhibitors"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M1697",
            "InterventionBrowseLeafName": "Decitabine",
            "InterventionBrowseLeafAsFound": "Text",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M3433",
            "InterventionBrowseLeafName": "Antimetabolites",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "ANeo",
            "InterventionBrowseBranchName": "Antineoplastic Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}